Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Philogen announced a collaboration and license agreement with Boehringer Ingelheim to discover and optimize novel small molecule-based therapeutics using Philochem’s ESAC Library Technology platform.
read more
Takeda and Schrödinger announced the formation of a multi-target research collaboration directed to diseases that align with Takeda’s core therapeutic areas of interest.
read more
The Catalent Applied Drug Delivery Institute today announced that it has entered into a collaboration with the Department of Pharmacy Practice at Rutgers University, with a view to identify and address the specific challenges of pediatric formulation...
read more
HemaCare has signed a long term lease to relocate its operations and corporate headquarters to a larger nearby site in the San Fernando Valley.
read more
STA Pharmaceutical has signed a supply agreement with oncology-focused biopharmaceutical company, TESARO for certain starting and intermediate materials for ZEJULA.
read more
ACG Worldwide has hired Richard Stedman as Group CEO for its Engineering business units. ACG serves customers in 100 countries through its network of 15 global manufacturing facilities.
read more
SQI Diagnostics announced a technology development partnership and licensing agreement with the McMaster University Department of Engineering to develop chip technology for use in multi-array disease testing.
read more
The gastrointestinal wall is a significant site of first-pass metabolism for oral drugs, which is commonly associated with CYP450 and UGT enzymes.
read more
Takeda and BioSurfaces have entered into an agreement to initiate a research program designed to develop innovative medical devices to treat patients with GI diseases using BioSurfaces’ proprietary nanomaterial technology.
read more
Walgreens Boots Alliance announced a binding offer from Fareva for a 10-year global agreement for the manufacture and supply of own beauty brands and private label products.
read more
Patient identification Platform (Patient iP) announced a new partnership with Aprima Medical Software.
read more
Cryoport announced Novartis has signed an agreement contracting Cryoport over an initial three-year term for cryogenic logistics support of CTL019/CD19 CAR-T cell therapy.
read more
Medidata announced that BeiGene will expand its use of the Medidata Clinical Cloud to further digitize patient reporting for its oncology research studies.
read more
Debiopharm has been selected to receive a funding award from CARB-X to advance the development of its antibiotic Debio 1453, a FabI inhibitor specifically targeting N. gonorrhoeae.
read more
ClinicalStudyDataRequest.com (CSDR) has increased the number of trials available to more than 3,460.
read more